- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Opthea Ltd (OPT)
Opthea Ltd stock price live, this page displays ASX OPT stock exchange data. View the OPT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Opthea Ltd real time stock price chart below.
What Is the Opthea Ltd Stock Price Today?
The Opthea Ltd stock price today is 0.60.
What Is the Stock Symbol for Opthea Ltd?
The stock symbol for Opthea Ltd is ""OPT.""
What Stock Exchange Does Opthea Ltd Trade On?
Opthea Ltd is listed and trades on the Sydney stock exchange.
Is Opthea Ltd a Good Stock to Buy?
Determining whether Opthea Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OPT quote. (ISIN: AU000000OPT2)
What Is the Opthea Ltd Stock Price Today?
The Opthea Ltd stock price today is 0.60.
What Is the Stock Symbol for Opthea Ltd?
The stock symbol for Opthea Ltd is ""OPT.""
What Stock Exchange Does Opthea Ltd Trade On?
Opthea Ltd is listed and trades on the Sydney stock exchange.
Is Opthea Ltd a Good Stock to Buy?
Determining whether Opthea Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OPT quote. (ISIN: AU000000OPT2)
0.60
0.00(0.00%)
Closed·
Fair Value
An estimate of a Opthea's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.60
0.62
52 wk Range
0.41
1.17
OPT Scorecard
Full Analysis
Quickly burning through cash
OPT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Opthea's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.600.62
52 wk Range
0.411.17
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
OPT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Opthea's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
1.42
Upside
+136.67%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
- Opthea Ltd shares corporate update in SEC filing
- Investing.com
- Optiva Inc. Announces Results of Annual Meeting
- Investing.com
- Opthea Halts Wet AMD Clinical Trials
- Investing.com
- Optiva Inc. Announces Results of Annual Meeting
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Opthea Ltd Company Profile
Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States. Its development activities are based on the intellectual property portfolio covering vascular endothelial growth factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company’s lead product candidate is sozinibercept (OPT-302), a biologic drug in Phase 3 clinical trials designed to inhibit VEGF-C and VEGF-D and complement VEGF-A inhibitors for the treatment of wet age-related macular degeneration and diabetic macular edema. It serves the biotechnology and healthcare industries. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is headquartered in Melbourne, Australia.
Compare OPT to Peers and Sector
Metrics to compare | OPT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOPTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.9x | −5.4x | −0.5x | |
PEG Ratio | −0.09 | 0.04 | 0.00 | |
Price/Book | −2.8x | 3.9x | 2.6x | |
Price / LTM Sales | 2,237.7x | 122.4x | 3.3x | |
Upside (Analyst Target) | 150.0% | 116.6% | 42.8% | |
Fair Value Upside | Unlock | −12.5% | 6.5% | Unlock |
Analyst Ratings
1 Buy
0 Hold
1 Sell
Ratings:
2 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 1.42
(+136.67% Upside)
Earnings
Latest Release
Feb 27, 2025
EPS / Forecast
-0.11 / -12.00
Revenue / Forecast
149.00K / 50.00K
People Also Watch
FAQ
What Stock Exchange Does Opthea Trade On?
Opthea is listed and trades on the Sydney Stock Exchange stock exchange.
What Is the Stock Symbol for Opthea?
The stock symbol for Opthea is "OPT."
What Is the Opthea Market Cap?
As of today, Opthea market cap is 738.77M.
What Is Opthea's Earnings Per Share (TTM)?
The Opthea EPS (TTM) is -0.26.
From a Technical Analysis Perspective, Is OPT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Opthea Stock Split?
Opthea has split 1 times.
How Many Employees Does Opthea Have?
Opthea has 33 employees.
What is the current trading status of Opthea (OPT)?
As of 06 Aug 2025, Opthea (OPT) is trading at a price of 0.60, with a previous close of 0.60. The stock has fluctuated within a day range of 0.60 to 0.62, while its 52-week range spans from 0.41 to 1.17.
What Is Opthea (OPT) Price Target According to Analysts?
The average 12-month price target for Opthea is AUD1.42, with a high estimate of AUD2.71 and a low estimate of AUD0.05. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +136.67% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.